Ionis Pharmaceuticals (IONS) Tops Q4 EPS by $1.13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- US stock futures muted as oil stays above $100 ahead of earnings
- Oil prices fluctuate on Trump's Russian diesel comments, attacks on Saudi
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Join SI Premium – FREE
Ionis Pharmaceuticals (NASDAQ: IONS) reported Q4 EPS of $1.41, $1.13 better than the analyst estimate of $0.28. Revenue for the quarter came in at $440 million versus the consensus estimate of $259.15 million.
For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Downgrades UWM Holdings Corp. (UWMC) to Neutral
- Elevance (ELV) PT Raised to $460 at Guggenheim
- DHT Holdings reports Q3 2026 TCE earnings of $141,300 per day
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
